Literature DB >> 22031696

Activation mechanism of the β2-adrenergic receptor.

Ron O Dror1, Daniel H Arlow, Paul Maragakis, Thomas J Mildorf, Albert C Pan, Huafeng Xu, David W Borhani, David E Shaw.   

Abstract

A third of marketed drugs act by binding to a G-protein-coupled receptor (GPCR) and either triggering or preventing receptor activation. Although recent crystal structures have provided snapshots of both active and inactive functional states of GPCRs, these structures do not reveal the mechanism by which GPCRs transition between these states. Here we propose an activation mechanism for the β(2)-adrenergic receptor, a prototypical GPCR, based on atomic-level simulations in which an agonist-bound receptor transitions spontaneously from the active to the inactive crystallographically observed conformation. A loosely coupled allosteric network, comprising three regions that can each switch individually between multiple distinct conformations, links small perturbations at the extracellular drug-binding site to large conformational changes at the intracellular G-protein-binding site. Our simulations also exhibit an intermediate that may represent a receptor conformation to which a G protein binds during activation, and suggest that the first structural changes during receptor activation often take place on the intracellular side of the receptor, far from the drug-binding site. By capturing this fundamental signaling process in atomic detail, our results may provide a foundation for the design of drugs that control receptor signaling more precisely by stabilizing specific receptor conformations.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22031696      PMCID: PMC3219117          DOI: 10.1073/pnas.1110499108

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  38 in total

Review 1.  The evasive nature of drug efficacy: implications for drug discovery.

Authors:  Ségolène Galandrin; Geneviève Oligny-Longpré; Michel Bouvier
Journal:  Trends Pharmacol Sci       Date:  2007-07-19       Impact factor: 14.819

Review 2.  Ligand binding and micro-switches in 7TM receptor structures.

Authors:  Rie Nygaard; Thomas M Frimurer; Birgitte Holst; Mette M Rosenkilde; Thue W Schwartz
Journal:  Trends Pharmacol Sci       Date:  2009-04-16       Impact factor: 14.819

3.  Crystal structure of the ligand-free G-protein-coupled receptor opsin.

Authors:  Jung Hee Park; Patrick Scheerer; Klaus Peter Hofmann; Hui-Woog Choe; Oliver Peter Ernst
Journal:  Nature       Date:  2008-06-18       Impact factor: 49.962

Review 4.  Activation of G protein-coupled receptors: beyond two-state models and tertiary conformational changes.

Authors:  Paul S-H Park; David T Lodowski; Krzysztof Palczewski
Journal:  Annu Rev Pharmacol Toxicol       Date:  2008       Impact factor: 13.820

5.  Crystal structure of metarhodopsin II.

Authors:  Hui-Woog Choe; Yong Ju Kim; Jung Hee Park; Takefumi Morizumi; Emil F Pai; Norbert Krauss; Klaus Peter Hofmann; Patrick Scheerer; Oliver P Ernst
Journal:  Nature       Date:  2011-03-09       Impact factor: 49.962

6.  Tracking G-protein-coupled receptor activation using genetically encoded infrared probes.

Authors:  Shixin Ye; Ekaterina Zaitseva; Gianluigi Caltabiano; Gebhard F X Schertler; Thomas P Sakmar; Xavier Deupi; Reiner Vogel
Journal:  Nature       Date:  2010-04-11       Impact factor: 49.962

Review 7.  Structure and activation of the visual pigment rhodopsin.

Authors:  Steven O Smith
Journal:  Annu Rev Biophys       Date:  2010       Impact factor: 12.981

8.  Internal hydration increases during activation of the G-protein-coupled receptor rhodopsin.

Authors:  Alan Grossfield; Michael C Pitman; Scott E Feller; Olivier Soubias; Klaus Gawrisch
Journal:  J Mol Biol       Date:  2008-05-22       Impact factor: 5.469

9.  Measurement of the millisecond activation switch of G protein-coupled receptors in living cells.

Authors:  Jean-Pierre Vilardaga; Moritz Bünemann; Cornelius Krasel; Mariàn Castro; Martin J Lohse
Journal:  Nat Biotechnol       Date:  2003-06-15       Impact factor: 54.908

10.  Agonist-bound adenosine A2A receptor structures reveal common features of GPCR activation.

Authors:  Guillaume Lebon; Tony Warne; Patricia C Edwards; Kirstie Bennett; Christopher J Langmead; Andrew G W Leslie; Christopher G Tate
Journal:  Nature       Date:  2011-05-18       Impact factor: 49.962

View more
  210 in total

1.  Development and characterization of pepducins as Gs-biased allosteric agonists.

Authors:  Richard Carr; Yang Du; Julie Quoyer; Reynold A Panettieri; Jay M Janz; Michel Bouvier; Brian K Kobilka; Jeffrey L Benovic
Journal:  J Biol Chem       Date:  2014-11-13       Impact factor: 5.157

2.  Dynamics and structural determinants of ligand recognition of the 5-HT6 receptor.

Authors:  Márton Vass; Balázs Jójárt; Ferenc Bogár; Gábor Paragi; György M Keserű; Ákos Tarcsay
Journal:  J Comput Aided Mol Des       Date:  2015-11-16       Impact factor: 3.686

3.  Responsiveness of G protein-coupled odorant receptors is partially attributed to the activation mechanism.

Authors:  Yiqun Yu; Claire A de March; Mengjue J Ni; Kaylin A Adipietro; Jérôme Golebiowski; Hiroaki Matsunami; Minghong Ma
Journal:  Proc Natl Acad Sci U S A       Date:  2015-11-16       Impact factor: 11.205

4.  Communication over the network of binary switches regulates the activation of A2A adenosine receptor.

Authors:  Yoonji Lee; Sun Choi; Changbong Hyeon
Journal:  PLoS Comput Biol       Date:  2015-02-09       Impact factor: 4.475

5.  Comparison of dynamics of extracellular accesses to the β(1) and β(2) adrenoceptors binding sites uncovers the potential of kinetic basis of antagonist selectivity.

Authors:  Balaji Selvam; Jeff Wereszczynski; Irina G Tikhonova
Journal:  Chem Biol Drug Des       Date:  2012-05-02       Impact factor: 2.817

6.  Molecular dynamics: A stitch in time.

Authors:  Xavier Deupi
Journal:  Nat Chem       Date:  2013-12-15       Impact factor: 24.427

7.  Identification of Distinct Conformations of the Angiotensin-II Type 1 Receptor Associated with the Gq/11 Protein Pathway and the β-Arrestin Pathway Using Molecular Dynamics Simulations.

Authors:  Jérôme Cabana; Brian Holleran; Richard Leduc; Emanuel Escher; Gaétan Guillemette; Pierre Lavigne
Journal:  J Biol Chem       Date:  2015-05-01       Impact factor: 5.157

8.  Mechanism of Hormone Peptide Activation of a GPCR: Angiotensin II Activated State of AT1R Initiated by van der Waals Attraction.

Authors:  Khuraijam Dhanachandra Singh; Hamiyet Unal; Russell Desnoyer; Sadashiva S Karnik
Journal:  J Chem Inf Model       Date:  2019-01-16       Impact factor: 4.956

9.  Molecular basis of cannabinoid CB1 receptor coupling to the G protein heterotrimer Gαiβγ: identification of key CB1 contacts with the C-terminal helix α5 of Gαi.

Authors:  Joong-Youn Shim; Kwang H Ahn; Debra A Kendall
Journal:  J Biol Chem       Date:  2013-10-03       Impact factor: 5.157

10.  Single-molecule view of basal activity and activation mechanisms of the G protein-coupled receptor β2AR.

Authors:  Rajan Lamichhane; Jeffrey J Liu; Goran Pljevaljcic; Kate L White; Edwin van der Schans; Vsevolod Katritch; Raymond C Stevens; Kurt Wüthrich; David P Millar
Journal:  Proc Natl Acad Sci U S A       Date:  2015-11-02       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.